Runs single-cell microbiology panels that identify organisms and report antimicrobial susceptibility from a patient specimen the same day, without overnight culture. Its pneumonia and urine panels both hold FDA Breakthrough Device designations.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.